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Abstract 
Background. Healthcare acquired infections (HAI) cause an increase of burden and in particular excess 
length of hospital stay (LOS) accounts for approximately up to 90% of total costs. Therefore accurate 
estimation of extra hospital stay due to healthcare acquired infections is very important. 
Methods. The authors carried out a review comparing the principal methods internationally used for 
estimating the excess LOS attributable to healthcare acquired infections. 
Results. The methods described and analysed are: 1) Implicit physician assessment; 2) appropriateness 
evaluation protocol; 3) unmatched case-control; 4) matched case-control; 5) regression analysis; 6) multistate 
model. The various methodologies are described underlining advantages and limits which researchers need 
to know before starting any economic analysis.
Conclusions. Overall, studies taking into account the time-dependent nature of HAI show to give more 
precise and reliable results.
Introduction
Healthcare acquired infections (HAI) are 
a recognized important cause of morbidity, 
mortality and economic burden for hospitals 
(1-4).
The increasing antimicrobial resistance 
raises concerns regarding the impact on 
patients with multidrug resistant organisms. 
Consequently important efforts have been 
made to study the clinical outcomes among 
patients infected with such pathogens, 
showing higher mortality and frequent 
treatment failure among them compared 
with those infected with the susceptible 
isolates (4-7).
While many findings have been achieved 
on clinical issues, our knowledge on the 
economic impact by multidrug resistant 
infections needs to be widened.
Overall, HAI economic burden is divided 
into direct and indirect costs. Direct costs 
are represented principally by additional 
hospital stay, drug treatment, medical and 
surgical procedures; indirect costs by the 
patients’ salary loss, relatives’ time and 
infirmity. Because it is difficult to evaluate 
exactly all variables, especially indirect 
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costs, investigators generally estimate only 
direct extra costs and particularly length of 
hospital stay (LOS), which may account for 
approximately up to 90% of total costs (2, 
3, 8-10).
Consequently, as researchers have 
developed various methodologies to assess 
the HAI-attributable extra stay, we decided 
to carry out this study to describe and 
evaluate them. 
Implicit physician assessment
It is a subjective method, for each 
patient with a confirmed HAI diagnosis, 
the physician or trained nurse reviews 
the clinical record and any other relevant 
clinical information such as nursing record, 
laboratory data, X-rays. Considering all 
data and applying implicit criteria the 
reviewer judges whether any single day of 
hospitalization should be attributed to the 
HAI or not.
This system is simple and needs a limited 
amount of resources to be applied. Also, 
differently from the comparison methods, 
includes in the study only the cases and no 
controls.
Therefore, already in the 1930’, it was 
adopted by some to evaluate the benefit of a 
new type of wound dressing (11). After the 
war, Goodall et al. (12) carried out a study 
in 13 wards of 8 hospitals and estimated an 
hospital prolonged stay of 21 days. Also others 
applied the same methodology to estimate 
the extra days of hospitalization caused by 
surgical wound infection (13) These various 
studies showed large differences in the final 
extended LOS reported estimates, may be 
because of differences in patient groups and 
data collection (14).
The implicit physician assessment 
primary disadvantages are represented by 
the high degree of subjectivity in applying 
implicit criteria and low interrater reliability 
for estimates of additional days of care.
This method consistently yields the 
lowest estimates of additional days due 
to HAI compared to other methods and is 
thought to underestimate the true incremental 
stay (15).
Comparing the implicit physician 
assessment to the matched comparison 
method Haley et al. (14) found that the 
former estimated extra days were 2.5 times 
less than the latter. The explanation may be 
that the reviewer tends to attribute extra days 
only if they are clearly the consequence of a 
nosocomial infection and therefore estimates 
obtained by this method might underestimate 
the true magnitude. However, this system 
may provide a valid minimal estimate (14).
Appropriateness evaluation protocol
The appropriateness evaluation protocol 
(AEP) was designed to overcome many of 
the methodological concerns associated with 
the historical cohort approach (16). This 
method assumes that all pertinent clinical 
information, in order to determine whether 
each day of stay can be justified by care for 
the original causes of the hospitalization or 
directly by the HAI, are contained in the 
medical record. The AEP is a diagnosis 
independent, objective method using explicit 
criteria to determine need for hospital 
admission and for each day of inpatient 
care.
In order to identify the additional days 
due to HAI, each day of hospitalization is 
evaluated twice using two different sets of 
criteria. The first (full AEP questionnaire) 
uses all the medical and nursing available 
information in the record, to determine 
whether each day in hospital is required for 
care of the patient including HAI. The second 
questionnaire (partial AEP), which excludes 
all information related to the treatment 
of nosocomial infection (e.g. antibiotics), 
identifies the days in hospital necessary 
in the absence of HAI. Therefore days of 
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hospitalization for which the full AEP review 
indicates need for acute care, but for which 
the partial AEP review does not, are attributed 
to the nosocomial infection. In short the 
only reason the patient is hospitalized is for 
management of the HAI (15).
Combining these two reviews yields 
one of the following decisions for each 
day reviewed: 1) HAI-attributed day where 
the full AEP review indicates yes and the 
partial AEP review indicates no; 2) non-
HAI-attributed day where either the full 
AEP review indicates yes and the partial 
AEP review also indicates yes, or the full 
AEP review indicates no and the partial AEP 
review also indicates no (17).
The AEP system using the case as a 
control of itself eliminates some limits 
present in the comparison methods and it can 
be considered as an evolution of the implicit 
physician assessment (18-19). However, 
it needs highly trained personnel and the 
questionnaires (full and partial) require 
modifications according to the patients 
characteristics (20).
Unmatched case-control
The unmatched group comparison 
method determines the hospital extra stay 
by comparing two patient groups: those 
with and those without HAI. Differences in 
total hospital days between uninfected and 
infected groups are then attributed to the 
nosocomial infection. This system is based 
on the assumption that any difference in LOS 
between infected and uninfected patients 
is attributable to the HAI. Generally the 
comparison is carried out using the average 
stay of cases (infected) and of all the other 
patients (uninfected) (15).
The major advantage of this method 
is represented by the use of inexpensive, 
Table 1 - Characteristics of methodologies to estimate excess lentgh of stay due to healthcare acquired infections
Methodology Advantages Limits Quality
Implicit assessment Easy to perform; Limited resources Subjective method; Not stan-
dardized
Medium
Appropriatenss evaluation 
protocol
Eliminates controls bias; Objective meth-
od
Highly trained personnel; 
Questionnaires modification 
according to patients charac-
teristics; 
High
Unmatched case-control Inexpensive; Readly available data Controls bias; Overestimates 
incremental stay caused by 
infection
Low
Matched case-control 
(Not t ime-dependent 
matching)
Reduces partially the bias of unmatched 
conrol studies
Number of criteria may reduce 
available controls, excluding 
some cases from analysis
Medium
Matched case-control
(Time-dependent match-
ing)
Corrects the bias of unmatched conrol stud-
ies (Length of stay in controls not inferior 
to length of stay in cases fron admission 
to infection)
Number of criteria may reduce 
available controls, excluding 
some cases from analysis
High
Regression analysis Includes almost all infected and uninfected 
patients
Highly trained personnel; 
Need to know specific clini-
cal data
High
Multi-state model Includes almost all infected and uninfected 
patients
Highly trained personnel; 
Need to know specific clini-
cal data
High
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readily available LOS data. The principal 
disadvantage is the implicit assumption that 
any difference in extra stay is attributable 
only to infection and not related to any other 
inherent difference between the two groups. 
The HAI group may have a propensity for 
longer LOS independently from any infection. 
Haley et al. showed that the estimates by the 
unmatched method were 25% greater than 
the matched estimates (14).
Therefore, this system is considered to 
overestimate the incremental stay caused by 
infection and may represent an upper limit 
for increased attributable days (8, 15). Also it 
could be useful to give rapid estimates of extra 
costs, but would need to be followed by more 
precise and analytical studies (21-22).
Matched case-control
This system overcomes the limits of the 
unmatched comparison method by matching 
patients who have an HAI with similar but 
uninfected controls using criteria such as 
age, sex, surgical procedure, diagnosis, risk 
factors, gravity score (APACHE, SAPS 
II). Extra hospital stay is estimated by 
subtracting the LOS of the controls from 
the LOS in cases. The difference is directly 
attributed to the infection (15).
For each infected patient is selected an 
uninfected hospitalized patient and matched 
with the patient according to a hierarchy of 
characteristics such as discharge diagnosis 
according to the International Classification 
of Disease Ninth Revision – Clinical 
Modification (ICD-9-CM) code, inpatient 
areas, the main procedure performed at the 
first surgical procedure, gender, and age. An 
ideal matching should include all potential 
confounding factors and to improve the 
matching a point scoring system has been 
introduced to quantify the appropriateness 
of control matching. 
This method assumes that patients 
developing HAI are not otherwise predisposed 
to requiring longer LOS independently of 
the infection. Second, an ideal case-control 
matching process should incorporate the full 
range of potential confounding variables, 
and this data are not always available. Thus, 
as the number and specificity of variables 
used to match cases and controls increase, 
the potential pool of control matches may 
be insufficient and result in the exclusion of 
cases for which no control can be matched 
(17).
Of various methods used to estimate extra 
hospital stay caused by HAI the matched case-
control method is among the most appropriate 
and used (2, 9). Many researchers adopted it 
even for large studies (23-27).
However, because it assumes that any 
difference in LOS is attributable to infection 
and not related to other inherent differences 
between the two patient groups, it is generally 
considered to overestimate slightly the 
attributable days and costs (15, 17, 28-29).
To improve matching some investigators 
introduced a point  scoring system 
which measures precisely the matching 
appropriateness of controls (10).
Other authors included additional criteria: 
the LOS of the controls should not be less 
than the time interval between admission and 
infection of the cases. Matching methods 
should match on time to infection requiring 
that the control patient have to spend 
an equivalent time in hospital. This not 
completely eliminates time-dependent bias 
but it significantly reduces it. Once the pairs 
are matched, the estimation of the number 
extra days is obtained subtracting the LOS 
of the non-infected patient from that of the 
infected patient and then averaged the extra 
LOS (8, 10, 28-30).
Regression analysis
Matching presents some disadvantages, 
as matching for many variables requires a 
substantial increase in the size of the pool 
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of controls which is not always possible, and 
matching too few variables might cause bias 
from “omitted variables” because important 
factors that explain the variation in cost 
outcomes are excluded. The consequence 
is that the cost attributed to HAI may be 
either overstated or understated. Also, if case 
patients are subsequently excluded from the 
study to match more variables (ie, to mitigate 
bias from omitted variables), then a selection 
bias arises because not all case patients 
have the same opportunity to be included 
in the comparison of cost outcomes. Use of 
statistical regression analysis for a cohort of 
patients can avoid selection bias completely 
and presents an opportunity to reduce bias 
from omitted variables (31). 
The regression analysis approach enables 
the inclusion of almost all infected and 
uninfected patients in analysis, and therefore 
provides a means to avoid selection bias. 
Though vulnerable to the influence of 
endogenous variables, methods such as 
instrumental variable models have been 
developed in order to minimise the effects 
(2, 9, 32-33).
Regression analyses had not been used 
for extra LOS and costs estimations in the 
1980s. In the 1990s, there were three studies 
that had used regression analyses, and this 
number rose over 20 after 2000 (2, 32, 34-
35).
Multistate model
The multistate model is a suitable method 
to avoid time-dependent bias, offering 
a more precise estimation of extra LOS 
attributable to HAI, as well as many other 
cost-consuming in-hospital adverse events 
(36). The structure of a multistate model 
can be viewed as unexposed individuals 
moving into the exposure state only when 
the exposure occurs and into the final state 
when the study endpoint is observed. In a 
multistate model assessing the excess of 
LOS associated with HAI, the occurrence of 
HAI would be the time-dependent exposure 
status, and discharge and deaths would be the 
study endpoint, also discharge and death can 
be handled as separate outcomes (36). Many 
studies are carried out by this method (37).
However, multistate models have also 
some limitations. First, because a multistate 
model is a representation of events as they 
occur over time, individual patient-level data 
need to be collected on a daily basis and this 
may be costly in terms of labour. Second 
multistate models rely on two restricting 
assumptions: the probability of transition 
into the next state depends only on the 
current state, that is the future course of a 
patient (such as to be discharged or to die) is 
assumed to depend on the current HAI status 
and not on the time its diagnosis; it assumes 
that the exact time of the appearance of a 
HAI is known. The first restriction may 
be resolved by including the time since 
HAI diagnosis in a regression model for 
the multiple states. The second restriction 
might be more relevant in clinical trials 
with periodic follow-up visits of patients 
than in a hospital setting, where daily data 
records are currently available. Finally, 
the statistical analysis requires advanced 
statistical expertise (36). Also, a limitation 
of multi-state models in the past was that 
they were not able to control for patient 
characteristics (9).
Discussion
Overall methodologies characteristics 
to estimate excess LOS due to healthcare 
acquired infection are reported in Table 1.
The AEP-based method has the following 
advantages: the possibility to enroll all 
patients with HAI, evaluation based on the 
pattern of the care provided, availability of 
information in the medical records resulting 
in a greater accuracy for studying HAI. Extra 
LOS estimated with the AEP method is 
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smaller than with the matched and unmatched 
comparison. The AEP method may distinguish 
between extra LOS associated with infection 
and extra LOS because of treatment of the 
principal clinical problem for which the 
patient was hospitalized; the method make 
known cost distribution of various type of 
infection in different ward providing useful 
information for setting priorities in infection 
prevention programs. The method uses the 
patient as their own control and it corrects 
the common flaws of methods based on the 
assumption that the resources used by HAI 
can only be determined by measuring extra 
days of LOS of infected versus non infected 
patients: for these reasons, it appears to be 
more reliable than the other two classical 
methods (8, 18).
The unmatched and matched comparison 
methods produce different results because 
they change populations for comparison. The 
unmatched comparison compares patients 
with and without HAI, but this assumes that 
the two populations are homogeneous and 
does not consider potential risk factors which 
create a net difference between the two. The 
validity of the matched comparison depends 
on the quality of matching and a straight 
match can reduce the effects of confounding 
where severity of illness was accounted 
for. The adjusted mean difference in LOS 
between infected and uninfected patients is 
reduced when matched for age, gender, ward, 
primary diagnosis, comorbidity and surgical 
operations which, significantly reduced the 
average difference on the total level.
Ideally,  matching should obtain 
controls with the same risk factors of stay 
prolongation as cases, except for the presence 
of HAI. The main risk factors associated 
with increased LOS are age, discharge 
diagnosis or accompanying diseases, and 
complications during hospital stay. Because 
patients with HAI more frequently have 
other comorbidities associated, the matching 
may select controls systematically less 
ill than cases with a shorter duration of 
stay (selection bias). Furthermore, it is 
often difficult to find a control with the 
same characteristics of the patient and to 
include more background and risk factors 
would reduce the differences between the 
groups, but such an inclusion would on the 
other hand make the interpretation of the 
outcomes more difficult. This may lead to 
cases exclusion for which no control can be 
matched, resulting in the selection of a less 
representative subset (8, 19, 28). 
Independently of the matching problem, 
because only the LOS between the two groups 
(with and without infection) and not the pattern 
of the actual care rendered to the patient was 
taken to assess the HAI-attributable days in 
the unmatched and the matched comparison 
methods, it remains uncertain whether the 
differences may be really linked to the HAI. 
Several HAI-attributable days of stay based 
exclusively on differences in LOS may reflect 
differences in the basic care process, physician 
preferences and practices, and internal 
operational inefficiency that effect LOS rather 
than the presence of a HAI (17). Matching 
controls by “length of stay in controls equal 
to interval from admission to infection in 
cases” is considered a fundamental criterion 
as it allows to match on the timing of the 
infection minimizing significantly a possible 
bias (2, 9, 10). 
Although regression models can be very 
useful, when electronic data are available, to 
carry out studies on large populations, recent 
literature shows that the most interesting 
approach to estimate excess LOS is today 
represented by multi-state modelling (9).
Overall these methods can be grouped as 
“time-fixed” and “time-varying” according 
to their treatment of time dependence. 
Patients acquire HAI during their hospital 
stay, thus they have already spent some time 
in hospital before they become infected. This 
time requires specific consideration in the 
analysis by treating HAI as a time-dependent 
exposure. Many studies are prone to the 
“time-dependent bias”, including studies 
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that fail to treat nosocomial infection as a 
time-dependent exposure (38-39), therefore 
estimates from time-varying methods that 
control for time-dependent bias should be 
adopted (40).
Beyersman et al. (41) show that time-
dependent bias is large in methods such as 
regression analysis and survival analysis that 
do not normally treat HAI as a time-varying 
exposure. Widely used regression methods 
cannot control for the timing of events and 
caution should be exercised when applying 
or interpreting regression results. Regression 
methods to estimate excess LOS should only 
be used for associations rather than causal 
inference (38).
Matching methods should match on time 
to infection, requiring the control patient to 
have spent an equivalent time in hospital 
before the infection as the case (9). This 
might not completely eliminate independent 
bias but it will significantly reduce it. Nelson 
et al. compare three estimation strategies and 
show that matching on the time to infection 
can substantially reduce the bias (42).
The alarmingly increasing antimicrobial 
resistance raises global concerns regarding 
the impact on patients with MDR infections, 
which are expected to be more costly for 
healthcare systems than susceptible ones, as 
they cause a higher LOS in the hospital (43-
49). According to previous studies, a relevant 
increase in hospital stay following HAI 
due to multi-resistant organisms was found 
(4). Also these multiresistant infections put 
greater difficulties in prevention (50-52).
In addition to time dependence bias, 
studies should consider carefully case 
definitions, causative organisms, populations 
characteristics, risk factors and antimicrobial 
resistance in order to provide accurate data 
to support effective and efficient infection 
prevention and control interventions (2, 4, 
9). Differentiating between endemic and 
outbreak conditions (53). Among the latter 
there are some specific microorganisms on 
which there is limited data on costs (54-58).
Conclusions
Over the last decades various methodologies 
have been developed to assess excess LOS 
due to HAI, but quantifying the exact extra 
stay remains a challenging issue. 
The AEP methodology is well designed 
eliminating some limits present in the 
comparison methods, but has not been 
widely adopted because needs highly trained 
personnel and the questionnaires (full and 
partial) require frequent modifications 
according to the patients characteristics.
Unmatched case control studies have been 
largely used in the past but, because they 
overestimate the incremental stay caused by 
infection, there use today is limited.
Overall, studies that take into account the 
time-dependent nature of HAI show to give 
more precise and reliable results. Therefore, 
it is essential that matched methods should 
match on time to infection, requiring the 
control patients to have spent an equivalent 
time in hospital before the infection as the 
case (Tab. 1).
Similarly, regression and multi-state 
studies need to include time-varying 
exposure. 
In addition to time dependence bias, 
studies should consider carefully case 
definitions, causative organisms, populations 
characteristics, risk factors and antimicrobial 
resistance in order to provide accurate data 
to support effective and efficient infection 
prevention and control interventions.
Riassunto
Extra degenza ospedaliera causata dalle infezioni 
correlate all’assistenza: valutazione delle metodo-
logie
Introduzione. Le infezioni correlate all’assistenza 
(ICA) causano un aumento dei costi ed in particolare 
l’extra degenza ospedaliera costituisce circa il 90% dei 
costi totali. Quindi una stima accurata dell’extra degenza 
ospedaliera causata dalle infezioni correlate all’assisten-
za è molto importante. 
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Metodi. È stata effettuata una rassegna dei principali 
metodi impiegati a livello internazionale per stimare 
l’extra degenza ospedaliera attribuibile alle infezioni 
correlate all’assistenza. 
Risultati. I metodi descritti ed analizzati sono stati: 
1) l’autovalutazione del medico; 2) il protocollo di va-
lutazione dell’appropriatezza; 3) il caso-controllo senza 
matching; 4) il caso-controllo con matching; 5) l’analisi 
di regressione; 6) il modello multi-stato. Le varie meto-
dologie sono state descritte sottolineando i vantaggi ed i 
limiti che i ricercatori devono conoscere prima di iniziare 
un’analisi economica. 
Conclusioni. In generale, gli studi che includono 
la natura tempo-dipendente delle infezioni correlate 
all’assistenza si mostrano più precise ed affidabili nei 
risultati.
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